SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa

Real-world data on vaccine-elicited neutralising antibody responses for two-dose AZD1222 in African populations are limited. We assessed baseline SARS-CoV-2 seroprevalence and levels of protective neutralizing antibodies prior to vaccination rollout using binding antibodies analysis coupled with pse...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdullahi, Adam, Oladele, David, Owusu, Michael, Kemp, Steven A., Ayorinde, James, Salako, Abideen, Fink, Douglas, Ige, Fehintola, Ferreira, Isabella A. T. M., Meng, Bo, Sylverken, Augustina Angelina, Onwuamah, Chika, Boadu, Kwame Ofori, Osuolale, Kazeem, Frimpong, James Opoku, Abubakar, Rufai, Okuruawe, Azuka, Abdullahi, Haruna Wisso, Liboro, Gideon, Agyemang, Lawrence Duah, Ayisi-Boateng, Nana Kwame, Odubela, Oluwatosin, Ohihoin, Gregory, Ezechi, Oliver, Kamasah, Japhet Senyo, Ameyaw, Emmanuel, Arthur, Joshua, Kyei, Derrick Boakye, Owusu, Dorcas Ohui, Usman, Olagoke, Mogaji, Sunday, Dada, Adedamola, Agyei, George, Ebrahimi, Soraya, Gutierrez, Lourdes Ceron, Aliyu, Sani H., Doffinger, Rainer, Audu, Rosemary, Adegbola, Richard, Mlcochova, Petra, Phillips, Richard Odame, Solako, Babatunde Lawal, Gupta, Ravindra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574797/
https://www.ncbi.nlm.nih.gov/pubmed/36253377
http://dx.doi.org/10.1038/s41467-022-33792-x

Ejemplares similares

Ejemplares similares